The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Th2 differentiation is necessary for soft tissue fibrosis and lymphatic dysfunction resulting from lymphedema
Open accessAbstract
Lymphedema is a dreaded complication of cancer treatment. However, despite the fact that >5 million Americans are affected by this disorder, the development of effective treatments is limited by the fact that the pathology of lymphedema remains unknown. The purpose of these studies was to determine the role of inflammatory responses in lymphedema pathology. Using mouse models of lymphedema, as well as clinical lymphedema specimens, we show that lymphatic stasis results in a CD4 T-cell inflammation and T-helper 2 (Th2) differentiation. Using mice deficient in T cells or CD4 cells, we show that this inflammatory response is necessary for the pathological changes of lymphedema, including fibrosis, adipose deposition, and lymphatic dysfunction. Further, we show that inhibition of Th2 differentiation using interleukin-4 (IL-4) or IL-13 blockade prevents initiation and progression of lymphedema by decreasing tissue fibrosis and significantly improving lymphatic function, independent of lymphangiogenic growth factors. We show that CD4 inflammation is a critical regulator of tissue fibrosis and lymphatic dysfunction in lymphedema and that inhibition of Th2 differentiation markedly improves lymphatic function independent of lymphangiogenic cytokine expression. Notably, preventing and/or reversing the development of pathological tissue changes that occur in lymphedema may be a viable treatment strategy for this disorder.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CD4+ T cells and cytokine signaling are critical to the regulation of fibrosis and swelling in the mouse tail wound model of lymphedema (140, 141).”
From Transport and Immune Functions of the Lymphatic System. (2025) · cites this paper as [141]
Citations
Cites
Cellular and molecular mechanisms of fibrosis
Wynn, T. (2008) · The Journal of Pathology · doi:10.1002/path.2277 · Cited by 4,495
IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer
Neurath, M. F., & Finotto, S. (2011) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2011.02.003 · Cited by 584
Estimating the Population Burden of Lymphedema
Rockson, S. G., & Rivera, K. K. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1413.014 · Cited by 447
Self-citationLymphedema after gynecological cancer treatment
Beesley, V. L., Janda, M., Eakin, E., Obermair, A., & Battistutta, D. (2007) · Cancer · doi:10.1002/cncr.22684 · Cited by 374
Tammela, T., Saaristo, A. M., Holopainen, T., Lyytikkä, J., Kotronen, A., Pitkonen, M., Abo‐Ramadan, U., Ylä‐Herttuala, S., Petrova, T. V., & Alitalo, K. K. (2007) · Nature Medicine · doi:10.1038/nm1689 · Cited by 362
Brennan, M. J., & Miller, L. T. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19981215)83:12b+ · Cited by 244
Self-citationTriggers of IgE class switching and allergy development
Poulsen, L. K., & Hummelshøj, L. (2007) · Annals of Medicine · doi:10.1080/07853890701449354 · Cited by 231
Rutkowski, J. M., Moya, M. L., Johannes, J., Goldman, J., & Swartz, M. A. (2006) · Microvascular Research · doi:10.1016/j.mvr.2006.05.009 · Cited by 229
Inhibition of endogenous TGF-β signaling enhances lymphangiogenesis
Oka, M., Iwata, C., Suzuki, H. I., Kiyono, K., Morishita, Y., Watabe, T., Komuro, A., Kano, M. R., & Miyazono, K. (2008) · Blood · doi:10.1182/blood-2007-10-120337 · Cited by 226
T Lymphocytes Negatively Regulate Lymph Node Lymphatic Vessel Formation
Kataru, R. P., Kim, H., Jang, C., Choi, D. K., Koh, B. I., Kim, M., Gollamudi, S., Kim, Y.-K., Lee, S., & Koh, G. Y. (2011) · Immunity · doi:10.1016/j.immuni.2010.12.016 · Cited by 225
Flagged first, then by citations
Research works printed but not linked: 1
- 10.1002/(SICI)1097-0142(19981215)83:12B <2776::AID-CNCR25>3.0.CO;2-V · DOI
Cited by
Sorted by citations
Items 201–240 of 240
Thyroid Hormone Ameliorates Lymphedema by Suppressing Adipogenesis in a Murine Lymphedema Model
Choi, J., Lee, K.-H., Kim, J., Jeong, W., Jo, T., Lee, H. W., Park, Y. S., & Park, S. W. (2022) · Lymphatic Research and Biology · doi:10.1089/lrb.2021.0079 · Cited by 1
Jung, J. I., & Cho, H. K. (2025) · Journal of Yeungnam Medical Science · doi:10.12701/jyms.2025.42.23 · Cited by 1
Mesenchymal stem cell therapy for breast cancer‑related secondary lymphedema (Review)
Han, S., Cai, J., Zhang, Y., & Lu, F. (2025) · Molecular and Clinical Oncology · doi:10.3892/mco.2025.2868 · Cited by 1
Zhang, D., Zhao, X., Li, H., Chen, W., & Liu, C. (2025) · Supportive Care in Cancer · doi:10.1007/s00520-025-09861-4 · Cited by 1
Hansen, F. G., Jørgensen, M. G., Ingwersen, K. G., Kjær, C., Carstensen, L. F., Tambour, M., Gram, B., Thomsen, J. B., & Sørensen, J. A. (2025) · Cancers · doi:10.3390/cancers17233753 · Cited by 2
Local lymphatic circulation disorder: A key promoter of tissue inflammation and organ fibrosis
Wu, X., & Liu, C. (2026) · Life Sciences · doi:10.1016/j.lfs.2026.124575 · Cited by 1
Ridner, S. H., Smith, D. K., Kline‐Quiroz, C. M., Jensen, K. M., Sukari, A. W., Bhayani, M. K., Mehta, V., Shah, J. L., Willey, C. D., Dunlap, N., et al. (2026) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2026.07.030 · Cited by 1
Effect of Goreisan, a Traditional Japanese Medicine, on Rat Hindlimb Lymphedema
Kawakami, Z., Matsubara, Y., Ogura, K., Imamura, S., Iizuka, S., Zhang, N., Matsumoto, C., & Fujitsuka, N. (2024) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b23-00829 · Cited by 1
Roberts, A., Campbell, A.-C., Pollack, B. L., Montagna, G., Sevilimedu, V., Axelrod, B., Gomez, E. A., Giri, D. D., Morrow, M., Mehrara, B. J., et al. (2025) · Annals of Surgical Oncology · doi:10.1245/s10434-025-16977-8 · Cited by 1
Self-citationInvestigative strategies on lymphatic vessel modulation for treating lymphedema in future medicine
Kataru, R. P., Mehrara, B. J., & Kim, H. (2018) · Precision and Future Medicine · doi:10.23838/pfm.2018.00142 · Cited by 1
Self-citationLymph node transfer in the treatment of postmastectomy lymphedema
Viitanen, T. P. (2014) · UTUPub (University of Turku)
Torres, E. P. O. (2021) · Redalyc (Universidad Autónoma del Estado de México)
El síndrome de adaptación general al cambio
Levit, G. (2005) · Clinic: Revista técnica de baloncesto
The Effect of Presurgical and Postsurgical Topical Tacrolimus on Pedicled Flap Survival in Rats
Jung, W. F., Van, Y.-V. R., Huang, H., & Otterburn, D. M. (2022) · Annals of Plastic Surgery · doi:10.1097/sap.0000000000003205
New and Emerging Therapies for Lymphedema: Part II
Sibley, R. C., & Rockson, S. G. (2022) · Springer eBooks · doi:10.1007/978-3-030-93039-4_27
Self-citationNonsurgical Management of the Lymphedema Patient
Miller, M. A., Schaverien, M. V., & Chen, D. N. (2022) · Springer eBooks · doi:10.1007/978-3-030-93039-4_6
Johannessen, A. L., Alstrup, M., Hjortdal, V. E., Palmfeldt, J., Offersen, B. V., & Mohanakumar, S. (2024) · Plastic & Reconstructive Surgery Global Open · doi:10.1097/gox.0000000000005968
Immediate Lymphatic Reconstruction
Friedman, R., Johnson, A. R., & Singhal, D. (2024) · Springer eBooks · doi:10.1007/978-3-031-38809-5_15
Roberts, A., & Barrio, A. V. (2025) · Annals of Surgical Oncology · doi:10.1245/s10434-025-17125-y
Inflammatory Processes and Cellular Mechanisms
Laur, G. (2025) · Springer eBooks · doi:10.1007/978-981-96-8939-2_6
Validation of Indocyanine Green-Methylene Blue Dye in the Lymphedema Rat Tail Model
Lee, J. S., Jang, W., Cho, H. G., Kim, J. S., An, S. H., Na, S., Kang, B., Lee, J., Park, H. Y., Ryu, J. Y., et al. (2026) · Biomedicines · doi:10.3390/biomedicines14020324
PRL2/PTP4A2, a modulator of lymphatic functions and inflammation
Magaut, R. (2023) · theses.fr (ABES) · doi:10.70675/bf04d860z767fz4413z8ba9z70496d71fff7
Mechanisms and treatments of lymphedema
Ren, H., Gong, Y., Zhang, S., Liu, J., Shen, J., Gizinger, O., Aripova, T., & Liu, J. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1827439
Plau, J., Cassina, C., Wolf, S., Grünherz, L., Zurfluh, C. E., Giovanoli, P., Gousopoulos, E., & Lindenblatt, N. (2026) · Lymphatic Research and Biology · doi:10.1177/15578585261452772
Sunavala‐Dossabhoy, G., Khanna, S., & Kim, D. D. (2026) · Oral Oncology Reports · doi:10.1016/j.oor.2026.100792
From stasis to systematics: deciphering the pathophysiology of secondary lymphedema through omics
Stull-Lane, A. R., Chen, X., Book, A. J., Kratchmarov, R., Pal, S., Shin, J. Y., Ashokan, G., Hespe, G. E., Mehrara, B. J., & Kataru, R. P. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1850725
Self-citationKakimi, K., Kobayashi, Y., & Nagaoka, K. (2026) · Immuno · doi:10.3390/immuno6030047
Racial and ethnic disparities in T helper 2-mediated inflammatory skin disorders
Pollack, B. L., Roberts, A., Wagner, B. D., Ashokan, G., Chen, X., Hespe, G. E., Shin, J., Stull-Lane, A. R., Pal, S., Mehrara, B. J., et al. (2026) · Skin Health and Disease · doi:10.1093/skinhd/vzag124
Self-citationKoll, K. K., Zimmermann, M. M., Schulte, M., Panayi, A. C., Hundeshagen, G., Kneser, U., & Hirche, C. (2026) · Scientific Reports · doi:10.1038/s41598-026-64775-3
Wang, J.-W., & Jian, L.-N. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1899048
Diagnostic significance of ilioinguinal nodal uptake percentages in lower limb lymphoscintigraphy
Güler, E. (2026) · Nuclear Medicine Communications · doi:10.1097/mnm.0000000000002233
Long, X., Yuan, S., Luo, Z., Chen, Y., 肖顺娥, 邓呈亮, & Chen, J. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1904807
Šabović, E. K. M., Janić, M., & Ručigaj, T. P. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1980239
Özyiğit, E., Oğuzhanasiltürk, D. Ü., ÖZYİĞİT, Ö., & Zure, M. (2026) · Phlebology The Journal of Venous Disease · doi:10.1177/02683555261499797
Bahtiri, L., Bučan, A., Frendø, M., Remvig, C., & Hölmich, L. R. (2026) · Lymphatic Research and Biology · doi:10.1177/15578585261497922
Frowen, J. J., Rischin, D., Porceddu, S. V., Alexander, M., Dyer, M., Ahmad, H. A. E., Fua, T. F., Iulio, J. D., Pizzolla, A., & Gough, K. (2026) · BMJ Open · doi:10.1136/bmjopen-2026-125077
Association between autoimmune diseases and risk of developing breast cancer-related lymphedema
Wagner, B. D., Brown, S., Barrio, A. V., Amburn, T., Polidorio, N., Le, T., Boe, L., Kataru, R. P., Hespe, G. E., Coriddi, M. R., et al. (2026) · npj Autoimmunity · doi:10.1038/s44483-026-00004-3
Self-citation
Metadata
- Authors
- Avraham, T., Zampell, J. C., Yan, A., Elhadad, S., Weitman, E. S., Rockson, S. G., Bromberg, J., & Mehrara, B. J.
- Affiliations
- Memorial Sloan Kettering Cancer Center (US)
- Division of Plastic and Reconstructive Surgery Department of Surgery New York New York USA
- Stanford Medicine (US)
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2012-11-27
- Volume
- 27
- Issue
- 3
- Pages
- 1114-1126
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- PMC
- PMC3574290
- OpenAlex
- W2102471792
- Cited by
- 241
- References
- 42
- Citations by year
- 2026: 22 · 2025: 21 · 2024: 19 · 2023: 26 · 2022: 24 · 2021: 24 · 2020: 16 · 2019: 21 · 2018: 12 · 2017: 16 · 2016: 10 · 2015: 12 · 2014: 12 · 2013: 4
- FWCI
- 4.43
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- The FASEB Journal (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Defense (BC103691)
- National Heart, Lung, and Blood Institute
- National Institutes of Health (R01HL111130)
- Center for Scientific Review (P30 CA08748)
- Topics
- Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
- Health Sciences › Medicine › Surgery › Lymphatic Disorders and Treatments
- Health Sciences › Medicine › Infectious Diseases › Parasitic Diseases Research and Treatment
- Keywords
- lymphedema, Th2 differentiation, fibrosis, lymphatic dysfunction, lymphatic stasis, IL-4, IL-13, lymphangiogenesis, cancer treatment complications, lymphedema treatment
- MeSH terms
- Animals, Cell Differentiation, Disease Models, Animal, Fibrosis, Inflammation, Lymphedema, Mice, Nude, Interleukin-4, Mice, Knockout, Th2 Cells, Interleukin-13, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
